de Groot Mary, Pinkerman Brenda, Wagner Julie, Hockman Erin
Department of Psychology, Ohio University, 239 Porter Hall, Athens, OH 45701, USA.
Diabetes Care. 2006 Mar;29(3):549-53. doi: 10.2337/diacare.29.03.06.dc05-1396.
To assess rates of depressive symptoms, depression treatment, and satisfaction in a multicultural sample of individuals with type 1 and type 2 diabetes.
This study was conducted with a cross-sectional community-based survey design.
The sample (n = 221) was predominantly female (60.3%), had type 2 diabetes (75%), and was middle class with a mean (+/-SD) age of 54 +/- 12 years. A total of 53% were white. Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression Scale (CESD) (mean 16.4 +/- 11.3). Using conservative thresholds (CESD score > or =22), 25.3% of participants reported clinically significant depression. Rates of depression did not differ by ethnic group or diabetes type. The majority (76%) of depressed participants reported treatment (52% antidepressants, 63% mental health providers, 19% alternative healers, and 15% herbal remedies). African Americans were less likely to report any depression treatment, to receive antidepressant medications, or receive treatment from a mental health professional compared with whites. Participants with high depressive symptoms reported general satisfaction with depression treatment experiences.
High rates of depressive symptoms were observed across ethnic groups, yet significant differences in use of depression treatment existed across ethnic groups. Those seeking depression treatment reported satisfaction with a variety of depression treatment modalities. Increased depression screening and treatment may be beneficial for ethnically diverse patients with type 1 and type 2 diabetes.
评估1型和2型糖尿病患者多元文化样本中的抑郁症状发生率、抑郁症治疗情况及满意度。
本研究采用基于社区的横断面调查设计。
样本(n = 221)以女性为主(60.3%),患有2型糖尿病(75%),为中产阶级,平均(±标准差)年龄为54±12岁。共有53%为白人。使用流行病学研究中心抑郁量表(CESD)评估抑郁症状(平均16.4±11.3)。采用保守阈值(CESD评分≥22),25.3%的参与者报告有临床显著抑郁。抑郁发生率在种族或糖尿病类型上无差异。大多数(76%)抑郁参与者报告接受了治疗(52%使用抗抑郁药,63%看心理健康专家,19%看替代疗法治疗师,15%使用草药)。与白人相比,非裔美国人报告接受任何抑郁症治疗、接受抗抑郁药物治疗或接受心理健康专业人员治疗的可能性较小。抑郁症状严重的参与者对抑郁症治疗经历总体满意。
各民族抑郁症状发生率均较高,但各民族在抑郁症治疗的使用上存在显著差异。寻求抑郁症治疗的人对多种抑郁症治疗方式表示满意。增加抑郁症筛查和治疗可能对1型和2型糖尿病的不同种族患者有益。